Transcriptomics Market by Product & Services (Consumables, Instruments, Software & Services), Technology (Next-Generation Sequencing, PCR-based Technologies), Application (Drug Discovery & Development, Clinical Diagnostic), and End User - Global Forecast
Description
Transcriptomics Market by Product & Services, Technology (Next-Generation Sequencing, PCR-based Technologies), Application (Drug Discovery & Development, Clinical Diagnostic), End User, and Geography - Forecast to 2035
According to the research report titled, 'Transcriptomics Market by Product & Services (Consumables, Instruments, Software & Services), Technology (Next-Generation Sequencing, PCR-based Technologies), Application (Drug Discovery & Development, Clinical Diagnostic), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes), and Geography - Global Forecast to 2035,' the transcriptomics market is projected to reach $15.32 billion by 2035, at a CAGR of 6.3% during the forecast period 2025-2035. The report provides an in-depth analysis of the global transcriptomics market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2035.
Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The growth of this market is driven by rapid advancements in next-generation sequencing (NGS) technologies, growing demand for personalized medicine, increasing prevalence of cancer and chronic diseases, expanding applications in drug discovery and development, and declining sequencing costs. Moreover, integration of single-cell and spatial transcriptomics workflows, rise of multi-omics approaches, implementation of artificial intelligence and machine learning in data analysis, expansion of clinical transcriptomics for diagnostics, and growing government funding for genomics research are expected to support the market's growth.
The key players operating in the transcriptomics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), QIAGEN N.V. (Netherlands), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), 10x Genomics, Inc. (U.S.), Takara Bio Inc. (Japan), Oxford Nanopore Technologies Ltd. (U.K.), Pacific Biosciences of California, Inc. (U.S.), Merck KGaA (Germany), Bruker Corporation (U.S.), PerkinElmer, Inc. (U.S.), Fluidigm Corporation (U.S.), and Promega Corporation (U.S.).
The transcriptomics market is segmented by product & services (consumables, instruments, and software & services), technology (next-generation sequencing, microarrays, PCR-based technologies, and other technologies), application (drug discovery & development, clinical diagnostics, personalized medicine, agricultural & animal research, and other applications), end user (pharmaceutical & biotechnology companies, academic & research institutes, clinical diagnostic laboratories, contract research organizations, and other end users), and geography. The study also evaluates industry competitors and analyzes the market at the country level.
Market Analysis by Segments
Based on Product & Services
The consumables segment is projected to account for the largest market share of approximately 51% in 2025. The dominance of this segment is primarily attributed to the recurring and high-volume nature of consumable usage across RNA-based workflows, continuous consumption of reagents for every sample processed, advancements in library preparation chemistries and automation-compatible reagent kits, and growing adoption of specialized consumables for low-input and single-cell samples. Transcriptomic studies require ongoing consumption of RNA extraction kits, library preparation kits, sequencing reagents, and PCR consumables, making this a key revenue driver for vendors.
However, the consumables segment is also expected to register the highest CAGR of 7.2% during the forecast period, driven by rising adoption of NGS-based RNA-seq and single-cell transcriptomics, expansion of sequencing service providers and decentralized testing, increasing throughput requirements across research and clinical settings, and development of innovative reagent formulations for emerging applications.
Based on Technology
The next-generation sequencing segment is expected to dominate the transcriptomics market in 2025, accounting for approximately 71% market share. This segment's leadership is primarily driven by comprehensive transcriptome coverage provided by NGS technologies, continuous decline in sequencing costs making NGS accessible to more laboratories, superior ability to detect novel transcripts and splice variants compared to other technologies, growing adoption of single-cell and spatial transcriptomics applications exclusively enabled by sequencing approaches, and preference for hypothesis-free discovery approaches. NGS enables unbiased transcriptome-wide analysis, providing insights into gene expression, alternative splicing, and transcript isoforms that are not possible with targeted methods.
The next-generation sequencing segment is also projected to register the highest CAGR of 7.3% during the forecast period, attributed to ongoing technological innovations improving sequencing accuracy and throughput, expanding applications in precision medicine and clinical diagnostics, increasing investments in genomics infrastructure by pharmaceutical and biotechnology companies, development of long-read sequencing technologies for comprehensive transcript characterization, and growing preference for comprehensive molecular profiling in research and clinical settings.
Based on Application
The drug discovery & development segment is expected to account for the largest share of approximately 35% of the transcriptomics market in 2025. This leadership is attributed to extensive use of transcriptomics throughout pharmaceutical development pipelines, growing investments in biologics and precision medicine requiring molecular characterization, increasing adoption of target-based drug discovery approaches, expanding applications in biomarker discovery for patient stratification, and utility in understanding mechanism of action and safety profiling. Pharmaceutical companies leverage transcriptomics to identify therapeutic targets, evaluate drug efficacy, understand treatment resistance mechanisms, and guide clinical trial design.
However, the personalized medicine segment is projected to register the highest CAGR of 8.0% during the forecast period, driven by increasing need for precise, patient-specific insights beyond traditional genetic testing, real-time measurement of gene expression for understanding disease pathways and drug response, rapid adoption of RNA-based biomarkers in oncology, immunology, and rare diseases, integration of precision medicine programs in healthcare systems, and growing requirement for transcriptomic profiling in guiding targeted therapies and monitoring therapeutic efficacy.
Based on End User
The pharmaceutical & biotechnology companies segment is expected to account for the largest share of approximately 40% of the transcriptomics market in 2025. This dominance is primarily driven by extensive use of transcriptomics throughout drug discovery and development pipelines, growing investments in precision medicine initiatives requiring molecular profiling, increasing adoption of transcriptomics in clinical trials for patient stratification, ongoing development of RNA-based therapeutics necessitating comprehensive transcriptomic characterization, and establishment of in-house sequencing capabilities for high-throughput analysis. These companies utilize transcriptomics for target identification, lead optimization, biomarker discovery, and companion diagnostics development.
Along with pharmaceutical & biotechnology companies, the contract research organizations (CROs) segment is also expected to register the highest CAGR of 7.1% during the forecast period. This rapid growth is driven by increasing outsourcing of RNA-seq, single-cell sequencing, and spatial transcriptomics services, complexity and high cost of advanced transcriptomic workflows making outsourcing attractive, CROs offering end-to-end solutions from sample preparation to bioinformatics interpretation, growing demand for specialized expertise and scalable infrastructure, and expansion of service portfolios to include cutting-edge technologies and AI-powered analytics.
Geographic Analysis
An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region.
North America is expected to account for the largest share of approximately 40% of the global transcriptomics market in 2025. This dominance is attributed to strong presence of leading biotechnology and pharmaceutical companies, well-established genomics research infrastructure, high adoption of advanced sequencing technologies, substantial government and private funding for genomics research through the National Institutes of Health and other organizations, and early adoption of transcriptomic diagnostics in clinical practice. The region benefits from comprehensive healthcare systems, major research institutions, and significant investments in precision medicine initiatives.
However, Asia-Pacific is projected to register the highest CAGR during the forecast period across the overall transcriptomics market. This growth is fueled by increasing investments in genomics research infrastructure, growing pharmaceutical and biotechnology sectors in countries like China and India, rising healthcare expenditure and improving access to advanced diagnostics, expanding academic research collaborations with Western institutions, government initiatives supporting precision medicine and genomics programs, and large-scale population genomics projects. Countries such as China have made substantial investments in genomics capabilities and launched national genomics programs. The region's growing middle-class population, improving healthcare infrastructure, increasing focus on personalized medicine, and supportive regulatory frameworks for genomics research are creating a conducive environment for market expansion. Additionally, the region's expanding clinical research activities, growing contract research organizations, and increasing pharmaceutical R&D investments contribute to higher adoption of transcriptomic technologies.
Key Questions Answered in the Report
What is the current revenue generated by the transcriptomics market globally?
At what rate is the global transcriptomics demand projected to grow for the next 7-10 years?
What are the historical market sizes and growth rates of the global transcriptomics market?
What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
Which segments in terms of product & services, technology, application, and end user are expected to create major traction for the manufacturers in this market?
What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global transcriptomics market?
Who are the major players in the global transcriptomics market? What are their specific product offerings in this market?
What are the recent strategic developments in the global transcriptomics market? What are the impacts of these strategic developments on the market?
Scope of the Report
Transcriptomics Market Assessment - by Product & Services
Consumables
Instruments
Software & Services
Transcriptomics Market Assessment - by Technology
Next-Generation Sequencing (NGS)
Microarrays
PCR-based Technologies
Other Technologies
Transcriptomics Market Assessment - by Application
Drug Discovery & Development
Clinical Diagnostics
Personalized Medicine
Agricultural & Animal Research
Other Applications
Transcriptomics Market Assessment - by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Clinical Diagnostic Laboratories
Contract Research Organizations (CROs)
Other End Users
Transcriptomics Market Assessment - by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Australia & New Zealand
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
Saudi Arabia
UAE
South Africa
Rest of Middle East & Africa
According to the research report titled, 'Transcriptomics Market by Product & Services (Consumables, Instruments, Software & Services), Technology (Next-Generation Sequencing, PCR-based Technologies), Application (Drug Discovery & Development, Clinical Diagnostic), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes), and Geography - Global Forecast to 2035,' the transcriptomics market is projected to reach $15.32 billion by 2035, at a CAGR of 6.3% during the forecast period 2025-2035. The report provides an in-depth analysis of the global transcriptomics market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2035.
Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The growth of this market is driven by rapid advancements in next-generation sequencing (NGS) technologies, growing demand for personalized medicine, increasing prevalence of cancer and chronic diseases, expanding applications in drug discovery and development, and declining sequencing costs. Moreover, integration of single-cell and spatial transcriptomics workflows, rise of multi-omics approaches, implementation of artificial intelligence and machine learning in data analysis, expansion of clinical transcriptomics for diagnostics, and growing government funding for genomics research are expected to support the market's growth.
The key players operating in the transcriptomics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), QIAGEN N.V. (Netherlands), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), 10x Genomics, Inc. (U.S.), Takara Bio Inc. (Japan), Oxford Nanopore Technologies Ltd. (U.K.), Pacific Biosciences of California, Inc. (U.S.), Merck KGaA (Germany), Bruker Corporation (U.S.), PerkinElmer, Inc. (U.S.), Fluidigm Corporation (U.S.), and Promega Corporation (U.S.).
The transcriptomics market is segmented by product & services (consumables, instruments, and software & services), technology (next-generation sequencing, microarrays, PCR-based technologies, and other technologies), application (drug discovery & development, clinical diagnostics, personalized medicine, agricultural & animal research, and other applications), end user (pharmaceutical & biotechnology companies, academic & research institutes, clinical diagnostic laboratories, contract research organizations, and other end users), and geography. The study also evaluates industry competitors and analyzes the market at the country level.
Market Analysis by Segments
Based on Product & Services
The consumables segment is projected to account for the largest market share of approximately 51% in 2025. The dominance of this segment is primarily attributed to the recurring and high-volume nature of consumable usage across RNA-based workflows, continuous consumption of reagents for every sample processed, advancements in library preparation chemistries and automation-compatible reagent kits, and growing adoption of specialized consumables for low-input and single-cell samples. Transcriptomic studies require ongoing consumption of RNA extraction kits, library preparation kits, sequencing reagents, and PCR consumables, making this a key revenue driver for vendors.
However, the consumables segment is also expected to register the highest CAGR of 7.2% during the forecast period, driven by rising adoption of NGS-based RNA-seq and single-cell transcriptomics, expansion of sequencing service providers and decentralized testing, increasing throughput requirements across research and clinical settings, and development of innovative reagent formulations for emerging applications.
Based on Technology
The next-generation sequencing segment is expected to dominate the transcriptomics market in 2025, accounting for approximately 71% market share. This segment's leadership is primarily driven by comprehensive transcriptome coverage provided by NGS technologies, continuous decline in sequencing costs making NGS accessible to more laboratories, superior ability to detect novel transcripts and splice variants compared to other technologies, growing adoption of single-cell and spatial transcriptomics applications exclusively enabled by sequencing approaches, and preference for hypothesis-free discovery approaches. NGS enables unbiased transcriptome-wide analysis, providing insights into gene expression, alternative splicing, and transcript isoforms that are not possible with targeted methods.
The next-generation sequencing segment is also projected to register the highest CAGR of 7.3% during the forecast period, attributed to ongoing technological innovations improving sequencing accuracy and throughput, expanding applications in precision medicine and clinical diagnostics, increasing investments in genomics infrastructure by pharmaceutical and biotechnology companies, development of long-read sequencing technologies for comprehensive transcript characterization, and growing preference for comprehensive molecular profiling in research and clinical settings.
Based on Application
The drug discovery & development segment is expected to account for the largest share of approximately 35% of the transcriptomics market in 2025. This leadership is attributed to extensive use of transcriptomics throughout pharmaceutical development pipelines, growing investments in biologics and precision medicine requiring molecular characterization, increasing adoption of target-based drug discovery approaches, expanding applications in biomarker discovery for patient stratification, and utility in understanding mechanism of action and safety profiling. Pharmaceutical companies leverage transcriptomics to identify therapeutic targets, evaluate drug efficacy, understand treatment resistance mechanisms, and guide clinical trial design.
However, the personalized medicine segment is projected to register the highest CAGR of 8.0% during the forecast period, driven by increasing need for precise, patient-specific insights beyond traditional genetic testing, real-time measurement of gene expression for understanding disease pathways and drug response, rapid adoption of RNA-based biomarkers in oncology, immunology, and rare diseases, integration of precision medicine programs in healthcare systems, and growing requirement for transcriptomic profiling in guiding targeted therapies and monitoring therapeutic efficacy.
Based on End User
The pharmaceutical & biotechnology companies segment is expected to account for the largest share of approximately 40% of the transcriptomics market in 2025. This dominance is primarily driven by extensive use of transcriptomics throughout drug discovery and development pipelines, growing investments in precision medicine initiatives requiring molecular profiling, increasing adoption of transcriptomics in clinical trials for patient stratification, ongoing development of RNA-based therapeutics necessitating comprehensive transcriptomic characterization, and establishment of in-house sequencing capabilities for high-throughput analysis. These companies utilize transcriptomics for target identification, lead optimization, biomarker discovery, and companion diagnostics development.
Along with pharmaceutical & biotechnology companies, the contract research organizations (CROs) segment is also expected to register the highest CAGR of 7.1% during the forecast period. This rapid growth is driven by increasing outsourcing of RNA-seq, single-cell sequencing, and spatial transcriptomics services, complexity and high cost of advanced transcriptomic workflows making outsourcing attractive, CROs offering end-to-end solutions from sample preparation to bioinformatics interpretation, growing demand for specialized expertise and scalable infrastructure, and expansion of service portfolios to include cutting-edge technologies and AI-powered analytics.
Geographic Analysis
An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region.
North America is expected to account for the largest share of approximately 40% of the global transcriptomics market in 2025. This dominance is attributed to strong presence of leading biotechnology and pharmaceutical companies, well-established genomics research infrastructure, high adoption of advanced sequencing technologies, substantial government and private funding for genomics research through the National Institutes of Health and other organizations, and early adoption of transcriptomic diagnostics in clinical practice. The region benefits from comprehensive healthcare systems, major research institutions, and significant investments in precision medicine initiatives.
However, Asia-Pacific is projected to register the highest CAGR during the forecast period across the overall transcriptomics market. This growth is fueled by increasing investments in genomics research infrastructure, growing pharmaceutical and biotechnology sectors in countries like China and India, rising healthcare expenditure and improving access to advanced diagnostics, expanding academic research collaborations with Western institutions, government initiatives supporting precision medicine and genomics programs, and large-scale population genomics projects. Countries such as China have made substantial investments in genomics capabilities and launched national genomics programs. The region's growing middle-class population, improving healthcare infrastructure, increasing focus on personalized medicine, and supportive regulatory frameworks for genomics research are creating a conducive environment for market expansion. Additionally, the region's expanding clinical research activities, growing contract research organizations, and increasing pharmaceutical R&D investments contribute to higher adoption of transcriptomic technologies.
Key Questions Answered in the Report
What is the current revenue generated by the transcriptomics market globally?
At what rate is the global transcriptomics demand projected to grow for the next 7-10 years?
What are the historical market sizes and growth rates of the global transcriptomics market?
What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
Which segments in terms of product & services, technology, application, and end user are expected to create major traction for the manufacturers in this market?
What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global transcriptomics market?
Who are the major players in the global transcriptomics market? What are their specific product offerings in this market?
What are the recent strategic developments in the global transcriptomics market? What are the impacts of these strategic developments on the market?
Scope of the Report
Transcriptomics Market Assessment - by Product & Services
Consumables
Instruments
Software & Services
Transcriptomics Market Assessment - by Technology
Next-Generation Sequencing (NGS)
Microarrays
PCR-based Technologies
Other Technologies
Transcriptomics Market Assessment - by Application
Drug Discovery & Development
Clinical Diagnostics
Personalized Medicine
Agricultural & Animal Research
Other Applications
Transcriptomics Market Assessment - by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Clinical Diagnostic Laboratories
Contract Research Organizations (CROs)
Other End Users
Transcriptomics Market Assessment - by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Australia & New Zealand
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
Saudi Arabia
UAE
South Africa
Rest of Middle East & Africa
Table of Contents
357 Pages
- 1 Introduction
- 1.1. Market Definition & Scope
- 1.2. Currency & Limitations
- 2 Research Methodology
- 2.1. Research Approach
- 2.2. Process of Data Collection and Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
- 2.3. Market Sizing and Forecasting
- 2.3.1. Market Size Estimation Approach
- 2.3.2. Growth Forecast Approach
- 2.4. Assumptions for the Study
- 3 Executive Summary
- 4 Market Insights
- 4.1. Overview
- 4.2. Factors Affecting Market Growth
- 4.2.1. Drivers
- 4.2.1.1. Increasing Demand for Personalized Medicine is Driving Market Growth
- 4.2.1.2. Rising Prevalence of Cancer and Chronic Diseases is Propelling the Market
- 4.2.1.3. Advancements in Next-Generation Sequencing Technologies Are Accelerating Market Expansion
- 4.2.1.4. Growing Applications in Drug Discovery and Development
- 4.2.1.5. Increasing Government Funding and Investments in Genomics Research
- 4.2.2. Restraints
- 4.2.2.1. High Cost of Transcriptomic Instruments and Services is Restraining Market Growth
- 4.2.2.2. Lack of Skilled Professionals for Data Analysis and Interpretation
- 4.2.2.3. Stringent Regulatory Requirements for Clinical Applications
- 4.2.3. Opportunities
- 4.2.3.1. Emerging Applications in Spatial Transcriptomics Offer Significant Growth Opportunities
- 4.2.3.2. Integration of Artificial Intelligence and Machine Learning in Data Analysis
- 4.2.3.3. Expanding Applications in Agricultural and Environmental Research
- 4.2.3.4. Growing Adoption in Emerging Markets
- 4.2.4. Challenges
- 4.2.4.1. Data Storage and Management Challenges
- 4.2.4.2. Lack of Standardization in Transcriptomic Workflows
- 4.2.5. Trends
- 4.2.5.1. Single-Cell Transcriptomics is Revolutionizing Biological Research
- 4.2.5.2. Long-Read Sequencing Technologies Are Enhancing Transcriptome Characterization
- 4.3. Regulatory Analysis
- 4.3.1. International Organization for Standardization (Iso)
- 4.3.2. North America
- 4.3.2.1. U.S.
- 4.3.2.2. Canada
- 4.3.3. Europe
- 4.3.4. Asia-Pacific
- 4.3.4.1. China
- 4.3.4.2. Japan
- 4.3.4.3. India
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa
- 4.4. Value Chain Analysis
- 4.4.1. Raw Material Suppliers
- 4.4.2. Component Manufacturers
- 4.4.3. Product Manufacturers
- 4.4.4. Distributors and Service Providers
- 4.4.5. End Users
- 4.4.6. Value Addition at Each Stage
- 5 Global Transcriptomics Market Assessment – By Product & Service
- 5.1. Overview
- 5.2. Consumables
- 5.2.1. RNA Extraction & Purification Kits
- 5.2.2. Library Preparation Kits
- 5.2.3. Sequencing Reagents & Kits
- 5.2.4. PCR Reagents & Kits
- 5.2.5. Other Consumables
- 5.3. Instruments
- 5.3.1. Sequencers
- 5.3.1.1. Next-Generation Sequencers
- 5.3.1.1.1. Third-Generation Sequencers
- 5.3.1.1.2. Sanger Sequencers
- 5.3.2. PCR Instruments
- 5.3.2.1. Real-Time PCR Systems
- 5.3.2.2. Digital PCR Systems
- 5.3.2.3. Standard PCR Systems
- 5.3.3. Other Instruments
- 5.4. Software and Services
- 5.4.1. Bioinformatics Software
- 5.4.1.1. Data Analysis Software
- 5.4.1.2. Data Management Software
- 5.4.2. Sequencing Services
- 5.4.3. Data Analysis Services
- 5.4.4. Other Services
- 6 Global Transcriptomics Market Assessment – By Technology
- 6.1. Overview
- 6.2. Next-Generation Sequencing (NGS)
- 6.2.1. RNA-Seq
- 6.2.2. Single-Cell RNA-Seq
- 6.2.3. Spatial Transcriptomics
- 6.2.4. Long-Read RNA Sequencing
- 6.2.5. Small RNA Sequencing
- 6.3. PCR-based Technologies
- 6.3.1. qRT-PCR
- 6.3.2. Digital PCR
- 6.3.3. Other PCR Expression Assays
- 6.4. Other Technologies
- 7 Global Transcriptomics Market Assessment – By Application
- 7.1. Overview
- 7.2. Drug Discovery & Development
- 7.2.1. Target Identification & Validation
- 7.2.2. Biomarker Discovery
- 7.2.3. Toxicology Studies
- 7.2.4. Lead Optimization
- 7.3. Clinical Diagnostics
- 7.3.1. Oncology Diagnostics
- 7.3.2. Infectious Disease Diagnostics
- 7.3.3. Genetic Disorder Diagnostics
- 7.3.4. Other Clinical Diagnostics
- 7.4. Personalized Medicine
- 7.5. Agricultural & Animal Research
- 7.6. Other Applications
- 8 Global Transcriptomics Market Assessment – By End User
- 8.1. Overview
- 8.2. Pharmaceutical & Biotechnology Companies
- 8.3. Academic & Research Institutes
- 8.4. Clinical Diagnostic Laboratories
- 8.5. Contract Research Organizations (Cros)
- 8.6. Other End Users
- 9 Transcriptomics Market Assessment, By Geography
- 9.1. Overview
- 9.2. North America
- 9.2.1. U.S.
- 9.2.2. Canada
- 9.3. Europe
- 9.3.1. Germany
- 9.3.2. U.K.
- 9.3.3. Italy
- 9.3.4. Spain
- 9.3.5. Switzerland
- 9.3.6. Belgium
- 9.3.7. Rest of Europe
- 9.4. Asia-Pacific
- 9.4.1. China
- 9.4.2. Japan
- 9.4.3. India
- 9.4.4. Australia
- 9.4.5. Rest of Asia-Pacific
- 9.5. Latin America
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
- 9.6. Middle East & Africa
- 9.6.1. UAE
- 9.6.2. Saudi Arabia
- 9.6.3. South Africa
- 9.6.4. Rest of Middle East & Africa
- 10 Competitive Landscape
- 10.1. Introduction
- 10.2. Key Growth Strategies
- 10.3. Competitive Benchmarking
- 10.4. Competitive Dashboard
- 10.4.1. Industry Leaders
- 10.4.2. Market Differentiators
- 10.4.3. Vanguards
- 10.4.4. Emerging Companies
- 10.5. Market Share/Position Analysis
- 11 Company Profiles
- 11.1. Illumina, Inc. (U.S.)
- 11.1.1. Company Overview
- 11.1.2. Financial Overview
- 11.1.3. Product Portfolio
- 11.1.4. Strategic Developments
- 11.2. Thermo Fisher Scientific, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Overview
- 11.2.3. Product Portfolio
- 11.2.4. Strategic Developments
- 11.3. Agilent Technologies, Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Overview
- 11.3.3. Product Portfolio
- 11.4. Qiagen N.V.
- 11.4.1. Company Overview
- 11.4.2. Financial Overview
- 11.4.3. Product Portfolio
- 11.4.4. Strategic Developments
- 11.5. Bio-Rad Laboratories, Inc.
- 11.5.1. Company Overview
- 11.5.2. Financial Overview
- 11.5.3. Product Portfolio
- 11.5.4. Strategic Developments
- 11.6. F. Hoffmann-La Roche Ltd. (U.S.)
- 11.6.1. Company Overview
- 11.6.2. Financial Overview
- 11.6.3. Product Portfolio
- 11.6.4. Strategic Developments
- 11.7. 10x Genomics, Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Overview
- 11.7.3. Product Portfolio
- 11.8. Takara Bio Inc. (U.S.)
- 11.8.1. Company Overview
- 11.8.2. Product Portfolio
- 11.8.3. Strategic Developments
- 11.9. Oxford Nanopore Technologies Ltd.
- 11.9.1. Company Overview
- 11.9.2. Product Portfolio
- 11.9.3. Strategic Developments
- 11.10. Pacific Biosciences of California, Inc.
- 11.10.1. Company Overview
- 11.10.2. Financial Overview
- 11.10.3. Product Portfolio
- 11.10.4. Strategic Developments
- 11.11. Merck Kgaa
- 11.11.1. Company Overview
- 11.11.2. Financial Overview
- 11.11.3. Product Portfolio
- 11.11.4. Swot Analysis
- 11.12. Bruker Corporation (U.S.)
- 11.12.1. Company Overview
- 11.12.2. Financial Overview
- 11.12.3. Product Portfolio
- 11.12.4. Strategic Developments
- 11.13. Perkinelmer, Inc. (U.S.)
- 11.13.1. Company Overview
- 11.13.2. Product Portfolio
- 11.14. Fluidigm Corporation (Standard Biotools Inc.)
- 11.14.1. Company Overview
- 11.14.2. Financial Overview
- 11.14.3. Product Portfolio
- 11.15. Promega Corporation
- 11.15.1. Company Overview
- 11.15.2. Product Portfolio
- 11.15.3. Strategic Developments
- 12 Appendix
- 12.1. Available Customization
- 12.2. Related Reports
- Table 1 Global Transcriptomics Market, by Product & Service, 2023-2035 (USD Million)
- Table 2 Global Transcriptomics Market, by Country/Region, 2023-2035 (USD Million)
- Table 3 Global Transcriptomics Consumables Market, by Type, 2023-2035 (USD Million)
- Table 4 Global Transcriptomics Consumables Market, by Country/Region, 2023-2035 (USD Million)
- Table 5 Global RNA Extraction & Purification Kits Market, by Country/Region, 2023-2035 (USD Million)
- Table 6 Global Library Preparation Kits Market, by Country/Region, 2023-2035 (USD Million)
- Table 7 Global Sequencing Reagents & Kits Market, by Country/Region, 2023-2035 (USD Million)
- Table 8 Global PCR Reagents & Kits Market, by Country/Region, 2023-2035 (USD Million)
- Table 9 Global Other Consumables Market, by Country/Region, 2023-2035 (USD Million)
- Table 10 Global Transcriptomics Instruments Market, by Type, 2023-2035 (USD Million)
- Table 11 Global Transcriptomics Instruments Market, by Country/Region, 2023-2035 (USD Million)
- Table 12 Global Sequencers Market, by Type, 2023-2035 (USD Million)
- Table 13 Global Sequencers Market, by Country/Region, 2023-2035 (USD Million)
- Table 14 Global Next-Generation Sequencers Market, by Type, 2023-2035 (USD Million)
- Table 15 Global Next-Generation Sequencers Market, by Country/Region, 2023-2035 (USD Million)
- Table 16 Global Third-Generation Sequencers Market, by Country/Region, 2023-2035 (USD Million)
- Table 17 Global Sanger Sequencers Market, by Country/Region, 2023-2035 (USD Million)
- Table 18 Global PCR Instruments Market, by Type, 2023-2035 (USD Million)
- Table 19 Global PCR Instruments Market, by Country/Region, 2023-2035 (USD Million)
- Table 20 Global Real-Time PCR Systems Market, by Country/Region, 2023-2035 (USD Million)
- Table 21 Global Digital PCR Systems Market, by Country/Region, 2023-2035 (USD Million)
- Table 22 Global Standard PCR Systems Market, by Country/Region, 2023-2035 (USD Million)
- Table 23 Global Other Instruments Market, by Country/Region, 2023-2035 (USD Million)
- Table 24 Global Transcriptomics Software & Services Market, by Type, 2023-2035 (USD Million)
- Table 25 Global Transcriptomics Software & Services Market, by Country/Region, 2023-2035 (USD Million)
- Table 26 Global Bioinformatics Software Market, by Type, 2023-2035 (USD Million)
- Table 27 Global Bioinformatics Software Market, by Country/Region, 2023-2035 (USD Million)
- Table 28 Global Data Analysis Software Market, by Country/Region, 2023-2035 (USD Million)
- Table 29 Global Data Management Software Market, by Country/Region, 2023-2035 (USD Million)
- Table 30 Global Sequencing Services Market, by Country/Region, 2023-2035 (USD Million)
- Table 31 Global Data Analysis Services Market, by Country/Region, 2023-2035 (USD Million)
- Table 32 Global Other Services Market, by Country/Region, 2023-2035 (USD Million)
- Table 33 Global Transcriptomics Market, by Technology, 2023-2035 (USD Million)
- Table 34 Global Next-Generation Sequencing (NGS) Market, by Type, 2023-2035 (USD Million)
- Table 35 Global Next-Generation Sequencing (NGS) Market, by Country/Region, 2023-2035 (USD Million)
- Table 36 Global RNA-Seq Market, by Country/Region, 2023-2035 (USD Million)
- Table 37 Global Single-Cell RNA-Seq Market, by Country/Region, 2023-2035 (USD Million)
- Table 38 Global Spatial Transcriptomics Market, by Country/Region, 2023-2035 (USD Million)
- Table 39 Global Long-Read RNA Sequencing Market, by Country/Region, 2023-2035 (USD Million)
- Table 40 Global Small RNA Sequencing Market, by Country/Region, 2023-2035 (USD Million)
- Table 41 Global PCR-Based Technologies Market, by Type, 2023-2035 (USD Million)
- Table 42 Global PCR-Based Technologies Market, by Country/Region, 2023-2035 (USD Million)
- Table 43 Global qRT-PCR Market, by Country/Region, 2023-2035 (USD Million)
- Table 44 Global Digital PCR Market, by Country/Region, 2023-2035 (USD Million)
- Table 45 Global Other PCR Expression Assays Market, by Country/Region, 2023-2035 (USD Million)
- Table 46 Global Other Technologies Market, by Country/Region, 2023-2035 (USD Million)
- Table 47 Global Transcriptomics Market, by Application, 2023-2035 (USD Million)
- Table 48 Global Transcriptomics Market for Drug Discovery & Development, by Type, 2023-2035 (USD Million)
- Table 49 Global Transcriptomics Market for Drug Discovery & Development, by Country/Region, 2023-2035 (USD Million)
- Table 50 Global Transcriptomics Market for Target Identification & Validation, by Country/Region, 2023-2035 (USD Million)
- Table 51 Global Transcriptomics Market for Biomarker Discovery, by Country/Region, 2023-2035 (USD Million)
- Table 52 Global Transcriptomics Market for Toxicology Studies, by Country/Region, 2023-2035 (USD Million)
- Table 53 Global Transcriptomics Market for Lead Optimization, by Country/Region, 2023-2035 (USD Million)
- Table 54 Global Transcriptomics Market for Clinical Diagnostics, by Type, 2023-2035 (USD Million)
- Table 55 Global Transcriptomics Market for Clinical Diagnostics, by Country/Region, 2023-2035 (USD Million)
- Table 56 Global Transcriptomics Market for Oncology Diagnostics, by Country/Region, 2023-2035 (USD Million)
- Table 57 Global Transcriptomics Market for Infectious Disease Diagnostics, by Country/Region, 2023-2035 (USD Million)
- Table 58 Global Transcriptomics Market for Genetic Disorder Diagnostics, by Country/Region, 2023-2035 (USD Million)
- Table 59 Global Transcriptomics Market for Other Clinical Diagnostics, by Country/Region, 2023-2035 (USD Million)
- Table 60 Global Transcriptomics Market for Personalized Medicine, by Country/Region, 2023-2035 (USD Million)
- Table 61 Global Transcriptomics Market for Agricultural & Animal Research, by Country/Region, 2023-2035 (USD Million)
- Table 62 Global Transcriptomics Market for Other Applications, by Country/Region, 2023-2035 (USD Million)
- Table 63 Global Transcriptomics Market, by End User, 2023-2035 (USD Million)
- Table 64 Global Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2023-2035 (USD Million)
- Table 65 Global Transcriptomics Market for Academic & Research Institutes, by Country/Region, 2023-2035 (USD Million)
- Table 66 Global Transcriptomics Market for Clinical Diagnostic Laboratories, by Country/Region, 2023-2035 (USD Million)
- Table 67 Global Transcriptomics Market for Contract Research Organizations (CROs), by Country/Region, 2023-2035 (USD Million)
- Table 68 Global Transcriptomics Market for Other End Users, by Country/Region, 2023-2035 (USD Million)
- Table 69 Global Transcriptomics Market, by Country/Region, 2023-2035 (USD Million)
- Table 70 North America: Transcriptomics Market, by Country, 2023-2035 (USD Million)
- Table 71 North America: Transcriptomics Market, by Product & Service, 2023-2035 (USD Million)
- Table 72 North America: Transcriptomics Consumables Market, by Type, 2023-2035 (USD Million)
- Table 73 North America: Transcriptomics Instruments Market, by Type, 2023-2035 (USD Million)
- Table 74 North America: Transcriptomics Sequencers Market, by Type, 2023-2035 (USD Million)
- Table 75 North America: Transcriptomics PCR Instruments Market, by Type, 2023-2035 (USD Million)
- Table 76 North America: Transcriptomics Software & Services Market, by Type, 2023-2035 (USD Million)
- Table 77 North America: Transcriptomics Bioinformatics Software Market, by Type, 2023-2035 (USD Million)
- Table 78 North America: Transcriptomics Market, by Technology, 2023-2035 (USD Million)
- Table 79 North America: Transcriptomics NGS Market, by Type, 2023-2035 (USD Million)
- Table 80 North America: Transcriptomics PCR-Based Technologies Market, by Type, 2023-2035 (USD Million)
- Table 81 North America: Transcriptomics Market, by Application, 2023-2035 (USD Million)
- Table 82 North America: Transcriptomics Market for Drug Discovery & Development, by Type, 2023-2035 (USD Million)
- Table 83 North America: Transcriptomics Market for Clinical Diagnostics, by Type, 2023-2035 (USD Million)
- Table 84 North America: Transcriptomics Market, by End User, 2023-2035 (USD Million)
- Table 85 U.S.: Transcriptomics Market, by Product & Service, 2023-2035 (USD Million)
- Table 86 U.S.: Transcriptomics Consumables Market, by Type, 2023-2035 (USD Million)
- Table 87 U.S.: Transcriptomics Instruments Market, by Type, 2023-2035 (USD Million)
- Table 88 U.S.: Transcriptomics Sequencers Market, by Type, 2023-2035 (USD Million)
- Table 89 U.S.: Transcriptomics PCR Instruments Market, by Type, 2023-2035 (USD Million)
- Table 90 U.S.: Transcriptomics Software & Services Market, by Type, 2023-2035 (USD Million)
- Table 91 U.S.: Transcriptomics Bioinformatics Software Market, by Type, 2023-2035 (USD Million)
- Table 92 U.S.: Transcriptomics Market, by Technology, 2023-2035 (USD Million)
- Table 93 U.S.: Transcriptomics NGS Market, by Type, 2023-2035 (USD Million)
- Table 94 U.S.: Transcriptomics PCR-Based Technologies Market, by Type, 2023-2035 (USD Million)
- Table 95 U.S.: Transcriptomics Market, by Application, 2023-2035 (USD Million)
- Table 96 U.S.: Transcriptomics Market for Drug Discovery & Development, by Type, 2023-2035 (USD Million)
- Table 97 U.S.: Transcriptomics Market for Clinical Diagnostics, by Type, 2023-2035 (USD Million)
- Table 98 U.S.: Transcriptomics Market, by End User, 2023-2035 (USD Million)
- Table 99 Canada: Transcriptomics Market, by Product & Service, 2023-2035 (USD Million)
- Table 100 Canada: Transcriptomics Consumables Market, by Type, 2023-2035 (USD Million)
- Table 101 Canada: Transcriptomics Instruments Market, by Type, 2023-2035 (USD Million)
- Table 102 Canada: Transcriptomics Sequencers Market, by Type, 2023-2035 (USD Million)
- Table 103 Canada: Transcriptomics PCR Instruments Market, by Type, 2023-2035 (USD Million)
- Table 104 Canada: Transcriptomics Software & Services Market, by Type, 2023-2035 (USD Million)
- Table 105 Canada: Transcriptomics Bioinformatics Software Market, by Type, 2023-2035 (USD Million)
- Table 106 Canada: Transcriptomics Market, by Technology, 2023-2035 (USD Million)
- Table 107 Canada: Transcriptomics NGS Market, by Type, 2023-2035 (USD Million)
- Table 108 Canada: Transcriptomics PCR-Based Technologies Market, by Type, 2023-2035 (USD Million)
- Table 109 Canada: Transcriptomics Market, by Application, 2023-2035 (USD Million)
- Table 110 Canada: Transcriptomics Market for Drug Discovery & Development, by Type, 2023-2035 (USD Million)
- Table 111 Canada: Transcriptomics Market for Clinical Diagnostics, by Type, 2023-2035 (USD Million)
- Table 112 Canada: Transcriptomics Market, by End User, 2023-2035 (USD Million)
- Table 113 Europe: Transcriptomics Market, by Country/Region, 2023-2035 (USD Million)
- Table 114 Europe: Transcriptomics Market, by Product & Service, 2023-2035 (USD Million)
- Table 115 Europe: Transcriptomics Consumables Market, by Type, 2023-2035 (USD Million)
- Table 116 Europe: Transcriptomics Instruments Market, by Type, 2023-2035 (USD Million)
- Table 117 Europe: Transcriptomics Sequencers Market, by Type, 2023-2035 (USD Million)
- Table 118 Europe: Transcriptomics PCR Instruments Market, by Type, 2023-2035 (USD Million)
- Table 119 Europe: Transcriptomics Software & Services Market, by Type, 2023-2035 (USD Million)
- Table 120 Europe: Transcriptomics Bioinformatics Software Market, by Type, 2023-2035 (USD Million)
- Table 121 Europe: Transcriptomics Market, by Technology, 2023-2035 (USD Million)
- Table 122 Europe: Transcriptomics NGS Market, by Type, 2023-2035 (USD Million)
- Table 123 Europe: Transcriptomics PCR-Based Technologies Market, by Type, 2023-2035 (USD Million)
- Table 124 Europe: Transcriptomics Market, by Application, 2023-2035 (USD Million)
- Table 125 Europe: Transcriptomics Market for Drug Discovery & Development, by Type, 2023-2035 (USD Million)
- Table 126 Europe: Transcriptomics Market for Clinical Diagnostics, by Type, 2023-2035 (USD Million)
- Table 127 Europe: Transcriptomics Market, by End User, 2023-2035 (USD Million)
- Table 128 Germany: Transcriptomics Market, by Product & Service, 2023-2035 (USD Million)
- Table 129 Germany: Transcriptomics Consumables Market, by Type, 2023-2035 (USD Million)
- Table 130 Germany: Transcriptomics Instruments Market, by Type, 2023-2035 (USD Million)
- Table 131 Germany: Transcriptomics Sequencers Market, by Type, 2023-2035 (USD Million)
- Table 132 Germany: Transcriptomics PCR Instruments Market, by Type, 2023-2035 (USD Million)
- Table 133 Germany: Transcriptomics Software & Services Market, by Type, 2023-2035 (USD Million)
- Table 134 Germany: Transcriptomics Bioinformatics Software Market, by Type, 2023-2035 (USD Million)
- Table 135 Germany: Transcriptomics Market, by Technology, 2023-2035 (USD Million)
- Table 136 Germany: Transcriptomics NGS Market, by Type, 2023-2035 (USD Million)
- Table 137 Germany: Transcriptomics PCR-Based Technologies Market, by Type, 2023-2035 (USD Million)
- Table 138 Germany: Transcriptomics Market, by Application, 2023-2035 (USD Million)
- Table 139 Germany: Transcriptomics Market for Drug Discovery & Development, by Type, 2023-2035 (USD Million)
- Table 140 Germany: Transcriptomics Market for Clinical Diagnostics, by Type, 2023-2035 (USD Million)
- Table 141 Germany: Transcriptomics Market, by End User, 2023-2035 (USD Million)
- Table 142 U.K.: Transcriptomics Market, by Product & Service, 2023-2035 (USD Million)
- Table 143 U.K.: Transcriptomics Consumables Market, by Type, 2023-2035 (USD Million)
- Table 144 U.K.: Transcriptomics Instruments Market, by Type, 2023-2035 (USD Million)
- Table 145 U.K.: Transcriptomics Sequencers Market, by Type, 2023-2035 (USD Million)
- Table 146 U.K.: Transcriptomics PCR Instruments Market, by Type, 2023-2035 (USD Million)
- Table 147 U.K.: Transcriptomics Software & Services Market, by Type, 2023-2035 (USD Million)
- Table 148 U.K.: Transcriptomics Bioinformatics Software Market, by Type, 2023-2035 (USD Million)
- Table 149 U.K.: Transcriptomics Market, by Technology, 2023-2035 (USD Million)
- Table 150 U.K.: Transcriptomics NGS Market, by Type, 2023-2035 (USD Million)
- Table 151 U.K.: Transcriptomics PCR-Based Technologies Market, by Type, 2023-2035 (USD Million)
- Table 152 U.K.: Transcriptomics Market, by Application, 2023-2035 (USD Million)
- Table 153 U.K.: Transcriptomics Market for Drug Discovery & Development, by Type, 2023-2035 (USD Million)
- Table 154 U.K.: Transcriptomics Market for Clinical Diagnostics, by Type, 2023-2035 (USD Million)
- Table 155 U.K.: Transcriptomics Market, by End User, 2023-2035 (USD Million)
- Table 156 Italy: Transcriptomics Market, by Product & Service, 2023-2035 (USD Million)
- Table 157 Italy: Transcriptomics Consumables Market, by Type, 2023-2035 (USD Million)
- Table 158 Italy: Transcriptomics Instruments Market, by Type, 2023-2035 (USD Million)
- Table 159 Italy: Transcriptomics Sequencers Market, by Type, 2023-2035 (USD Million)
- Table 160 Italy: Transcriptomics PCR Instruments Market, by Type, 2023-2035 (USD Million)
- Table 161 Italy: Transcriptomics Software & Services Market, by Type, 2023-2035 (USD Million)
- Table 162 Italy: Transcriptomics Bioinformatics Software Market, by Type, 2023-2035 (USD Million)
- Table 163 Italy: Transcriptomics Market, by Technology, 2023-2035 (USD Million)
- Table 164 Italy: Transcriptomics NGS Market, by Type, 2023-2035 (USD Million)
- Table 165 Italy: Transcriptomics PCR-Based Technologies Market, by Type, 2023-2035 (USD Million)
- Table 166 Italy: Transcriptomics Market, by Application, 2023-2035 (USD Million)
- Table 167 Italy: Transcriptomics Market for Drug Discovery & Development, by Type, 2023-2035 (USD Million)
- Table 168 Italy: Transcriptomics Market for Clinical Diagnostics, by Type, 2023-2035 (USD Million)
- Table 169 Italy: Transcriptomics Market, by End User, 2023-2035 (USD Million)
- Table 170 Spain: Transcriptomics Market, by Product & Service, 2023-2035 (USD Million)
- Table 171 Spain: Transcriptomics Consumables Market, by Type, 2023-2035 (USD Million)
- Table 172 Spain: Transcriptomics Instruments Market, by Type, 2023-2035 (USD Million)
- Table 173 Spain: Transcriptomics Sequencers Market, by Type, 2023-2035 (USD Million)
- Table 174 Spain: Transcriptomics PCR Instruments Market, by Type, 2023-2035 (USD Million)
- Table 175 Spain: Transcriptomics Software & Services Market, by Type, 2023-2035 (USD Million)
- Table 176 Spain: Transcriptomics Bioinformatics Software Market, by Type, 2023-2035 (USD Million)
- Table 177 Spain: Transcriptomics Market, by Technology, 2023-2035 (USD Million)
- Table 178 Spain: Transcriptomics NGS Market, by Type, 2023-2035 (USD Million)
- Table 179 Spain: Transcriptomics PCR-Based Technologies Market, by Type, 2023-2035 (USD Million)
- Table 180 Spain: Transcriptomics Market, by Application, 2023-2035 (USD Million)
- Table 181 Spain: Transcriptomics Market for Drug Discovery & Development, by Type, 2023-2035 (USD Million)
- Table 182 Spain: Transcriptomics Market for Clinical Diagnostics, by Type, 2023-2035 (USD Million)
- Table 183 Spain: Transcriptomics Market, by End User, 2023-2035 (USD Million)
- Table 184 Switzerland: Transcriptomics Market, by Product & Service, 2023-2035 (USD Million)
- Table 185 Switzerland: Transcriptomics Consumables Market, by Type, 2023-2035 (USD Million)
- Table 186 Switzerland: Transcriptomics Instruments Market, by Type, 2023-2035 (USD Million)
- Table 187 Switzerland: Transcriptomics Sequencers Market, by Type, 2023-2035 (USD Million)
- Table 188 Switzerland: Transcriptomics PCR Instruments Market, by Type, 2023-2035 (USD Million)
- Table 189 Switzerland: Transcriptomics Software & Services Market, by Type, 2023-2035 (USD Million)
- Table 190 Switzerland: Transcriptomics Bioinformatics Software Market, by Type, 2023-2035 (USD Million)
- Table 191 Switzerland: Transcriptomics Market, by Technology, 2023-2035 (USD Million)
- Table 192 Switzerland: Transcriptomics NGS Market, by Type, 2023-2035 (USD Million)
- Table 193 Switzerland: Transcriptomics PCR-Based Technologies Market, by Type, 2023-2035 (USD Million)
- Table 194 Switzerland: Transcriptomics Market, by Application, 2023-2035 (USD Million)
- Table 195 Switzerland: Transcriptomics Market for Drug Discovery & Development, by Type, 2023-2035 (USD Million)
- Table 196 Switzerland: Transcriptomics Market for Clinical Diagnostics, by Type, 2023-2035 (USD Million)
- Table 197 Switzerland: Transcriptomics Market, by End User, 2023-2035 (USD Million)
- Table 198 Belgium: Transcriptomics Market, by Product & Service, 2023-2035 (USD Million)
- Table 199 Belgium: Transcriptomics Consumables Market, by Type, 2023-2035 (USD Million)
- Table 200 Belgium: Transcriptomics Instruments Market, by Type, 2023-2035 (USD Million)
- Table 201 Belgium: Transcriptomics Sequencers Market, by Type, 2023-2035 (USD Million)
- Table 202 Belgium: Transcriptomics PCR Instruments Market, by Type, 2023-2035 (USD Million)
- Table 203 Belgium: Transcriptomics Software & Services Market, by Type, 2023-2035 (USD Million)
- Table 204 Belgium: Transcriptomics Bioinformatics Software Market, by Type, 2023-2035 (USD Million)
- Table 205 Belgium: Transcriptomics Market, by Technology, 2023-2035 (USD Million)
- Table 206 Belgium: Transcriptomics NGS Market, by Type, 2023-2035 (USD Million)
- Table 207 Belgium: Transcriptomics PCR-Based Technologies Market, by Type, 2023-2035 (USD Million)
- Table 208 Belgium: Transcriptomics Market, by Application, 2023-2035 (USD Million)
- Table 209 Belgium: Transcriptomics Market for Drug Discovery & Development, by Type, 2023-2035 (USD Million)
- Table 210 Belgium: Transcriptomics Market for Clinical Diagnostics, by Type, 2023-2035 (USD Million)
- Table 211 Belgium: Transcriptomics Market, by End User, 2023-2035 (USD Million)
- Table 212 Rest of Europe: Transcriptomics Market, by Product & Service, 2023-2035 (USD Million)
- Table 213 Rest of Europe: Transcriptomics Consumables Market, by Type, 2023-2035 (USD Million)
- Table 214 Rest of Europe: Transcriptomics Instruments Market, by Type, 2023-2035 (USD Million)
- Table 215 Rest of Europe: Transcriptomics Sequencers Market, by Type, 2023-2035 (USD Million)
- Table 216 Rest of Europe: Transcriptomics PCR Instruments Market, by Type, 2023-2035 (USD Million)
- Table 217 Rest of Europe: Transcriptomics Software & Services Market, by Type, 2023-2035 (USD Million)
- Table 218 Rest of Europe: Transcriptomics Bioinformatics Software Market, by Type, 2023-2035 (USD Million)
- Table 219 Rest of Europe: Transcriptomics Market, by Technology, 2023-2035 (USD Million)
- Table 220 Rest of Europe: Transcriptomics NGS Market, by Type, 2023-2035 (USD Million)
- Table 221 Rest of Europe: Transcriptomics PCR-Based Technologies Market, by Type, 2023-2035 (USD Million)
- Table 222 Rest of Europe: Transcriptomics Market, by Application, 2023-2035 (USD Million)
- Table 223 Rest of Europe: Transcriptomics Market for Drug Discovery & Development, by Type, 2023-2035 (USD Million)
- Table 224 Rest of Europe: Transcriptomics Market for Clinical Diagnostics, by Type, 2023-2035 (USD Million)
- Table 225 Rest of Europe: Transcriptomics Market, by End User, 2023-2035 (USD Million)
- Table 226 Asia-Pacific: Transcriptomics Market, by Country/Region, 2023-2035 (USD Million)
- Table 227 Asia-Pacific: Transcriptomics Market, by Product & Service, 2023-2035 (USD Million)
- Table 228 Asia-Pacific: Transcriptomics Consumables Market, by Type, 2023-2035 (USD Million)
- Table 229 Asia-Pacific: Transcriptomics Instruments Market, by Type, 2023-2035 (USD Million)
- Table 230 Asia-Pacific: Transcriptomics Sequencers Market, by Type, 2023-2035 (USD Million)
- Table 231 Asia-Pacific: Transcriptomics PCR Instruments Market, by Type, 2023-2035 (USD Million)
- Table 232 Asia-Pacific: Transcriptomics Software & Services Market, by Type, 2023-2035 (USD Million)
- Table 233 Asia-Pacific: Transcriptomics Bioinformatics Software Market, by Type, 2023-2035 (USD Million)
- Table 234 Asia-Pacific: Transcriptomics Market, by Technology, 2023-2035 (USD Million)
- Table 235 Asia-Pacific: Transcriptomics NGS Market, by Type, 2023-2035 (USD Million)
- Table 236 Asia-Pacific: Transcriptomics PCR-Based Technologies Market, by Type, 2023-2035 (USD Million)
- Table 237 Asia-Pacific: Transcriptomics Market, by Application, 2023-2035 (USD Million)
- Table 238 Asia-Pacific: Transcriptomics Market for Drug Discovery & Development, by Type, 2023-2035 (USD Million)
- Table 239 Asia-Pacific: Transcriptomics Market for Clinical Diagnostics, by Type, 2023-2035 (USD Million)
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
